Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Rocket Doctor AI ( (TSE:AIDR) ) just unveiled an announcement.
Rocket Doctor AI Inc. has launched a non-brokered private placement under Canada’s listed issuer financing exemption to raise a minimum of approximately $3 million through the sale of 4,285,715 units at $0.70 each, with each unit comprising one common share and a one-year warrant exercisable at $0.85. The financing, which may include finder’s fees and additional warrants, is expected to close around January 19, 2026, subject to minimum subscription and regulatory approvals, and the company plans to deploy the proceeds toward digital marketing and customer acquisition, operating and administrative costs, research and development, and general working capital, supporting its growth ambitions in AI-powered healthcare and expansion of its digital platform for physicians and patients.
The most recent analyst rating on (TSE:AIDR) stock is a Hold with a C$0.71 price target. To see the full list of analyst forecasts on Rocket Doctor AI stock, see the TSE:AIDR Stock Forecast page.
Spark’s Take on TSE:AIDR Stock
According to Spark, TipRanks’ AI Analyst, TSE:AIDR is a Neutral.
The score is primarily held down by weak financial performance—minimal revenue scale, large operating losses, and sharply worsening cash burn—implying high execution and funding risk. Technicals are also soft (negative MACD and price below short/intermediate moving averages). Offsetting factors include a string of positive corporate developments (U.S. insurer access expansion, funding/grants, partnerships, and an announced acquisition), but valuation support is limited given negative earnings and no dividend yield provided.
To see Spark’s full report on TSE:AIDR stock, click here.
More about Rocket Doctor AI
Rocket Doctor AI Inc. operates in the digital health and AI-driven healthcare technology sector, delivering physician-built, AI-powered solutions to improve access to high-quality care across the patient journey. Its core technology includes the Global Library of Medicine, a clinically validated decision support system created with input from hundreds of physicians, and an AI-powered virtual and hybrid practice platform that has enabled over 300 doctors to conduct more than 700,000 patient visits. The company focuses on reducing administrative burdens, enhancing physician autonomy, and expanding access to underserved, rural, and remote communities in Canada as well as patients on Medicaid and Medicare in the United States, positioning itself as a scalable, equitable, and patient-centered healthcare innovator.
Average Trading Volume: 213,379
Technical Sentiment Signal: Buy
Current Market Cap: C$63.73M
See more insights into AIDR stock on TipRanks’ Stock Analysis page.